Close
Innovation and Enterprise
We have a strong record of forming spin-out companies, and our academics have played critical roles in developing innovative cell and gene therapies against genetic diseases and cancer, and revolutionary medicines for rare diseases.
Learn more about how we work with commercial and industry partners to accelerate the translation of discovery science into new experimental treatments below.
Entrepreneurship
We collaborate closely with UCLB, UCL's commercialisation company, and its partner NHS Trusts to foster an entrepreneurial culture among staff, students, and alumni. Meet some of the visionary entrepreneurs who are developing groundbreaking technologies and innovations to enhance people's lives.
BoobyBiome, the pioneering female-founded startup dedicated to revolutionising infant health, proudly announces that its founders have been named in the prestigious Forbes Under 30 list for 2024.
A girl born with a rare and fatal genetic condition has been potentially cured of her disease thanks to a revolutionary gene therapy developed by UCL spinout Orchard Therapeutics (Orchard).
A free smartphone app, Drink Less, can help people who would benefit most from reducing their alcohol consumption to do so successfully, according to a large randomised controlled trial led by UCL researchers.
Expertise and consultancy
Our institutes offer extensive expertise across diverse and specialised fields. Through pioneering cross-disciplinary research, advanced technologies, and holistic healthcare strategies, we are dedicated to revolutionising the future of population health.
Social prescriptions for activities such as gardening, fishing, attending museums, as well arts and sports clubs are to be offered to children and adolescents who report high levels of loneliness or low community connection as part of a new four-year project led by faculty researchers.
UCL scientists will work to help thousands of people living with rare diseases get access to improved diagnostics, treatments and potentially cures, thanks to funding for four new research centres.
Professor John Deanfield (UCL Institute of Cardiovascular Science) is to lead a UK government taskforce to identify radical new approaches to prevent cardiovascular disease and reduce pressure on the NHS.
Partnerships
We collaborate with a diverse array of global partners from the public, private, and third sectors to unite people and organisations in transforming population health and wellbeing. In partnership with organisations like Cancer Research UK and NHS England, our research breakthroughs are advancing our understanding of disease.
The Lancet Countdown: Tracking Progress on Health and Climate Change brings together 35 leading academic institutions and UN agencies to monitor progress, empower health professionals and support policymakers.
Experts at UCL have teamed up with leading women’s health charities to design a new education and support programme for women across the country experiencing menopause.
The UCL Institute for Global Health is incredibly proud to host a World Health Organisation Collaboration Centre for TB Research and Innovation at UCL.
Students and alumni
Our inspiring students and graduates demonstrate innovative thinking and creative problem-solving to make a real difference. Here, we highlight the remarkable achievements of the students and alumni dedicated to creating a better future for all.
Two of the five UCL startups taking part were co-founded by FPHS graduates: MedQ and Your Cue..
.
Seven female trailblazers supported by UCL have won national awards in recognition of their game-changing ideas tackling some of the UK’s biggest challenges.
UCL MPH student Jennifer Uchendu, is recognised among the BBC's prestigious lineup of 100 inspiring and influential women worldwide for 2023.
Technology and licensing
Through licensing, joint IP development, industry research partnerships, and launching spin-out companies, we are pioneering truly revolutionary technologies.
A multi-disciplinary team of researchers, involving several UCL scientists, has developed a way to monitor the progression of movement disorders using motion capture technology and AI.
A new digital health hub, led by UCL researchers, will bring together an interdisciplinary team to better deploy digital technologies in the fight against antimicrobial resistance across humans, animals and the environment.
UCL IHI and GOSH Data Research, Innovation and Virtual Environments Unit (DRIVE) have agreed on a formal relationship which will enable the two world-leading teams to work more closely to accelerate health informatics and improve patient outcomes.